Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.120
+0.270 (14.59%)
At close: Oct 29, 2025, 4:00 PM EDT
1.990
-0.130 (-6.13%)
Pre-market: Oct 30, 2025, 9:27 AM EDT
Palisade Bio Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$12.00
Upside
+466.04%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital | Brookline Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +654.72% | May 13, 2025 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +1,692.45% | Nov 20, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $23 → $8 | Strong Buy | Maintains | $23 → $8 | +277.36% | Nov 13, 2024 |
| Maxim Group | Maxim Group | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +961.32% | May 1, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +961.32% | Apr 16, 2024 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $23 | Hold → Strong Buy | Upgrades | $23 | +961.32% | Nov 17, 2023 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $375 → $240 | Strong Buy | Maintains | $375 → $240 | +11,220.75% | May 16, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $750 | Hold → Strong Buy | Upgrades | $750 | +35,277.36% | Mar 30, 2023 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 19, 2022 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $3,750 | Strong Buy | Initiates | $3,750 | +176,786.79% | Feb 2, 2022 |
| Maxim Group | Maxim Group | Strong Buy Initiates $5,250 | Strong Buy | Initiates | $5,250 | +247,541.51% | Aug 31, 2021 |